Patients should maintain symptom diaries when experiencing persistent gastrointestinal issues, documenting timing, severity, and relationship to meals or medication administration
Additionally, individuals with autoimmune or gastrointestinal disorders, such as pernicious anemia, celiac, or Crohns disease, are more likely to be at risk of deficiency
And then when they go on the anti-estrogen therapies like the aromatase inhibitors, its really very difficult for people to lose weight I find, just with all the ovarian suppression and the estrogen suppression
Drugs like Semaglutide and Tirzepatide are making headlines and helping people achieve significant weight loss that once felt impossible
Unlike sermorelin, ipamorelin has yet to be approved by the FDA for any use and remains a research peptide with a paucity of data regarding its clinical effects